You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Mallinckrodt
Boehringer Ingelheim
Medtronic
Moodys

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for BIIB021


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for BIIB021?

BIIB021 is an investigational drug.

There have been 7 clinical trials for BIIB021. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Breast Neoplasms, Gastrointestinal Stromal Tumors, and Leukemia, Lymphoid. The leading clinical trial sponsors are Biogen and [disabled in preview].

Recent Clinical Trials for BIIB021
TitleSponsorPhase
Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule FindingBiogenPhase 2
Effect of Food and Antacid on BIIB021 With Advanced Solid TumorsBiogenPhase 1
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)BiogenPhase 2

See all BIIB021 clinical trials

Clinical Trial Summary for BIIB021

Top disease conditions for BIIB021
Top clinical trial sponsors for BIIB021

See all BIIB021 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Harvard Business School
Moodys
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.